Singapore markets closed

Augmedix, Inc. (AUGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1400-0.0400 (-3.39%)
At close: 03:53PM EST
1.1500 +0.01 (+0.88%)
After hours: 04:05PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 48.66M
Enterprise value 39.48M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.66
Price/book (mrq)7.54
Enterprise value/revenue 1.37
Enterprise value/EBITDA -1.83

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-68.95%
S&P500 52-week change 3-11.22%
52-week high 33.9000
52-week low 31.1000
50-day moving average 31.3428
200-day moving average 31.9462

Share statistics

Avg vol (3-month) 329.11k
Avg vol (10-day) 326.51k
Shares outstanding 537.43M
Implied shares outstanding 6N/A
Float 812.43M
% held by insiders 117.39%
% held by institutions 162.34%
Shares short (14 Nov 2022) 492.06k
Short ratio (14 Nov 2022) 45.42
Short % of float (14 Nov 2022) 40.64%
Short % of shares outstanding (14 Nov 2022) 40.25%
Shares short (prior month 13 Oct 2022) 497.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin -85.24%
Operating margin (ttm)-76.40%

Management effectiveness

Return on assets (ttm)-48.82%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)28.76M
Revenue per share (ttm)0.78
Quarterly revenue growth (yoy)39.80%
Gross profit (ttm)10.01M
EBITDA -21.2M
Net income avi to common (ttm)-24.52M
Diluted EPS (ttm)-0.5990
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.25M
Total cash per share (mrq)0.7
Total debt (mrq)17.07M
Total debt/equity (mrq)264.56
Current ratio (mrq)2.07
Book value per share (mrq)0.17

Cash flow statement

Operating cash flow (ttm)-17.67M
Levered free cash flow (ttm)-11.51M